Publications

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.

ISHOLA, D; Manno, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,

2021

Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00125-0.

Age groups that sustain resurging COVID-19 epidemics in the United States.

Monod, M; Blenkinsop, A; Xi, X; Hebert, D; Bershan, S; Tietze, S; BAGUELIN, M; Bradley, VC; Chen, Y; Coupland, H; Filippi, S; Ish-Horowicz, J; McManus, M; Mellan, T; Gandy, A; Hutchinson, M; Unwin, HJ T; Van Elsland, SL; Vollmer, MA C; Weber, S; Zhu, H; Bezancon, A; Ferguson, NM; Mishra, S; Flaxman, S; ... Imperial College COVID-19 Response Team,

2021

Science (New York, N.Y.), (2021).371 6536 10.1126/science.abe8372.

Unexposed populations and potential COVID-19 burden in European countries as of 21st November 2021.

CHAPMAN, LA C; BARNARD, RC; RUSSELL, TW; Abbott, S; VAN ZANDVOORT, K; DAVIES, NG; KUCHARSKI, AJ;

2021

, Zenodo (2021).

Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era.

BARNARD, R; DAVIES, N; JIT, M; EDMUNDS, J; Centre for Mathematical Modelling of Infectious Di,;

2021

medRxiv (2021). 10.1101/2021.11.22.21266584.

cmmid/coronavirus_immunity.

Waterlow, NR; Van Leeuwen, E; DAVIES, N; FLASCHE, S; EGGO, RM;

2021

, Github (2021).

Date of introduction and epidemiologic patterns of SARS-CoV-2 in Mogadishu, Somalia: estimates from transmission modelling of 2020 excess mortality data.

KOLTAI, M; Warsame, A; Bashiir, F; Freemantle, T; Williams, C; JIT, M; Flasche, S; DAVIES, N; Aweis, A; Ahmed, M; Dalmar, A; Checchi, F; CMMID COVID-19 working group,;

2021

medRxiv (2021). 10.1101/2021.06.15.21258924.

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections.

HELLEWELL, J; RUSSELL, TW; SAFER Investigators and Field Study Team,; Crick COVID-19 Consortium,; CMMID COVID-19 working group,; Beale, R; Kelly, G; Houlihan, C; Nastouli, E; KUCHARSKI, AJ;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-01982-x.

The Governance and Implementation of the National Action Plan on Antimicrobial Resistance in Tanzania: A Qualitative Study.

Frumence, G; Mboera, LE G; Sindato, C; Katale, BZ; Kimera, S; Metta, E; DURRANCE-BAGALE, A; JUNG, A-S; Mshana, SE; CLARK, TG; Rweyemamu, M; LEGIDO-QUIGLEY, H; Matee, MI N;

2021

Antibiotics, (2021).10 3 10.3390/antibiotics10030273.

COVID-19 vaccine challenges: What have we learned so far and what remains to be done?.

Forman, R; Shah, S; Jeurissen, P; JIT, M; Mossialos, E;

2021

Health policy (Amsterdam, Netherlands), (2021).125 5 10.1016/j.healthpol.2021.03.013.

Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study.

Portnoy, A; ABBAS, K; Sweet, S; Kim, JJ; JIT, M;

2021

BMJ Global Health, (2021).6 11 10.1136/bmjgh-2021-006940.